C1 esterase inhibitor recombinant Intravenous and Selegiline transdermal
Determining the interaction of C1 esterase inhibitor recombinant Intravenous and Selegiline transdermal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
Generic Name: selegiline
Brand name: Eldepryl, Zelapar, Emsam
Synonyms: Selegiline
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- C1 esterase inhibitor recombinant Intravenous-Selegiline Transdermal System
- C1 esterase inhibitor recombinant Intravenous-Selenicaps-200
- C1 esterase inhibitor recombinant Intravenous-Selenimin
- C1 esterase inhibitor recombinant Intravenous-Selenimin-200
- C1 esterase inhibitor recombinant Intravenous-Selenious Acid
- C1 esterase inhibitor recombinant Intravenous-Selenious Acid Injection
- Selegiline transdermal-C1 esterase inhibitor, human Intravenous
- Selegiline transdermal-C1 Inhibitor (Human)
- Selegiline transdermal-C1 Inhibitor (Human) (Berinert)
- Selegiline transdermal-C1 Inhibitor (Human) (Cinryze)
- Selegiline transdermal-C1 Inhibitor (Human) (Haegarda)
- Selegiline transdermal-C1 Inhibitor (Recombinant)